Affibody

About:

Affibody is a Swedish biotech company focused on developing products for therapy, diagnostic imaging, and other applications.

Website: http://www.affibody.se

Top Investors: European Investment Bank, KTH Holding, Kaupthing Bank

Description:

Affibody is a Swedish biotech company focused on developing next generation products for therapy, diagnostic imaging, and other applications based on its unique proprietary technology platforms: Affibody® molecules and Albumod™. Affibody® molecules, which are small, robust and easily produced, can be designed to bind specifically to a large number of target proteins. They have a broad range of applications including protein purification, enzyme inhibition, research reagents for protein capture and detection, diagnostics, including molecular imaging, and targeted therapeutics.

Total Funding Amount:

$49.9M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Stockholm, Stockholms Lan, Sweden

Founded Date:

1998-01-01

Contact Email:

reception(AT)affibody.com

Founders:

Mathias Uhlén

Number of Employees:

101-250

Last Funding Date:

2022-12-23

IPO Status:

Private

Industries:

© 2025 bioDAO.ai